Cardiovascular Intervention

Contributing journals to this collection:
JAMA & Archives Journals

Citations 251-260 of 842 total displayed.

Past content

Original Investigations
The Influence of Patient Adherence on Anticoagulation Control With Warfarin: Results From the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study

Stephen E. Kimmel; Zhen Chen; Maureen Price; Catherine S. Parker; Joshua P. Metlay; Jason D. Christie; Colleen M. Brensinger; Craig W. Newcomb; Frederick F. Samaha; Robert Gross
Arch Intern Med 2007; 167: 229-235. [Abstract] [Full text] [PDF]  

Original Investigations
Comparison of Outcomes Among Patients Randomized to Warfarin Therapy According to Anticoagulant Control: Results From SPORTIF III and V

Harvey D. White; Michael Gruber; Jan Feyzi; Scott Kaatz; Hung-Fat Tse; Steen Husted; Gregory W. Albers
Arch Intern Med 2007; 167: 239-245. [Abstract] [Full text] [PDF]  

Original Investigations
Newly Detected Atrial Fibrillation and Compliance With Antithrombotic Guidelines

Nicole L. Glazer; Sascha Dublin; Nicholas L. Smith; Benjamin French; Lisa A. Jackson; Jennifer B. Hrachovec; David S. Siscovick; Bruce M. Psaty; Susan R. Heckbert
Arch Intern Med 2007; 167: 246-252. [Abstract] [Full text] [PDF]  

Original Contributions
Mortality Associated With Aprotinin During 5 Years Following Coronary Artery Bypass Graft Surgery

Dennis T. Mangano; Yinghui Miao; Alain Vuylsteke; Iulia C. Tudor; Rajiv Juneja; Daniela Filipescu; Andreas Hoeft; Manuel L. Fontes; Zak Hillel; Elisabeth Ott; Tatiana Titov; Cynthia Dietzel; Jack Levin; for the Investigators of The Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation
JAMA 2007; 297: 471-479. [Abstract] [Full text] [PDF] [ JAMA News Video ]  

Editorials
Aprotinin—Are There Lessons Learned?

T. Bruce Ferguson Jr
JAMA 2007; 297: 527-529. [Extract] [Full text] [PDF]  

Original Contributions
Determinants of Outcome in Anticoagulation-Associated Cerebral Hematoma Requiring Emergency Evacuation

Alejandro A. Rabinstein; Eelco F. M. Wijdicks
Arch Neurol 2007; 64: 203-206. [Abstract] [Full text] [PDF]  

Letters
Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism

Huichun Zhan; Haoyi Zheng
JAMA 2007; 297: 261-a-262-a. [Extract] [Full text] [PDF]  

Letters
Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism

Darrell W. Harrington; Ayad Jindeel
JAMA 2007; 297: 262-a. [Extract] [Full text] [PDF]  

Letters
Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism

Jonathan Lee Edwards
JAMA 2007; 297: 262. [Extract] [Full text] [PDF]  

Letters
Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism—Reply

Clive Kearon; Jeffrey S. Ginsberg; Jim A. Julian; Michael Gent; for the Fixed-Dose Heparin (FIDO) Investigators
JAMA 2007; 297: 263. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85